Contact the Editorial Desk

Editorial correspondence

LuvThy Peptide welcomes correspondence on the research record: a citation quoted inaccurately, a regulatory status that has changed, or a peer-reviewed study on PT-141 or kisspeptin that should be reflected in the references page. Corrections that improve accuracy are the most useful messages this desk receives and are read carefully.

The most actionable notes specify three things: the page in question, the exact passage, and the supporting citation — a DOI or PubMed ID wherever possible. That allows verification against the source quickly.

Editorial mailbox: editors@luvthypeptide.com

What this desk cannot do

So that no message goes unanswered for the wrong reason, a few things fall outside what this site can address. LuvThy Peptide is a literature digest, not a clinic or a vendor.

• Advise on, recommend, or comment on human use of any compound described here.
• Suggest a dose, schedule, or route of administration for any individual.
• Comment on whether a research finding applies to a particular person or condition.
• Sell, source, recommend, or help locate any compound from any supplier.
• Advise athletes subject to anti-doping rules on whether or how to use these compounds.

Readers seeking medical guidance should consult a licensed clinician in their own jurisdiction. Responses to editorial correspondence are not guaranteed; the mailbox is monitored intermittently.